Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Action of antihypoxic agents on ischemic myocardial damage

This is a preview of subscription content, log in to check access.

Literature Cited

  1. 1.

    N. S. Bashirova, A. I. Usmankhodzhaev, and A. K. Paleologu, Vopr. Med. Khimii, No. 3, 61 (1985).

  2. 2.

    I. B. Tsorin and G. G. Chichkanov, Pharmacological Correction of Oxygen-Dependent Pathological States [in Russian], Moscow (1984), pp. 161–62.

  3. 3.

    G. G. Chichkanov and I. B. Tsorin, Farmakol. Toksikol., No. 2, 49 (1985).

  4. 4.

    P. J. Boor and E. S. Reynolds, Am. J. Clin. Path.,68, 387 (1977).

  5. 5.

    H. Boudoulas, P. E. Karayannacos, R. P. Lewis, et al., J. Surg. Res.,24, 469 (1978).

  6. 6.

    W. D. Bussman, D. Passek, W. Seidel, and M. Kaltenbach, Circulation,63, 615 (1981).

  7. 7.

    K. M. Fox, A. P. Selwyn, and E. Welman, Clin. Cardiol.,3, 47 (1980).

  8. 8.

    R. A. Kloner and E. Braunwald, Cardiovasc. Res.,14, 371 (1980).

  9. 9.

    T. Peter, M. K. Heng, B. N. Singh, et al., Circulation,57, 534 (1978).

  10. 10.

    S. B. Rosalki, J. Lab. Clin. Med.,69, 696 (1967).

  11. 11.

    A. I. Selye, E. Bajusz, S. Grasso, and B. Mendell, Angiology,11, 398 (1960).

  12. 12.

    W. E. Shell, J. E. Lavelle, J. W. Covell, and B. D. Sobel, J. Clin. Invest.,42, 114 (1973).

  13. 13.

    D. M. Yellon, J. M. Downey, and D. J. Hearse, G. Ital. Cardiol.,14, 892 (1984).

Download references

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Tsorin, I.P., Chichkanov, G.G. Action of antihypoxic agents on ischemic myocardial damage. Bull Exp Biol Med 102, 1566–1568 (1986). https://doi.org/10.1007/BF00854693

Download citation

Key Words

  • sodium hydroxybutyrate
  • pyracetam
  • pyridoxinyl-glyoxylate
  • creatine phosphokinase
  • myocardial infarction